Pfizer

Abstract: The European Commission has approved Pfizer`s first-of-its-kind oral Janus kinase (JAK) inhibitor  XELJANZ® (Tofacitinib) 5 mg twice daily for the treatment…

KEYPOINTS:  Pfizer Inc allow generic manufacturers to supply its experimental antiviral Covid-19 pill to 95 low- and middle-income countries. This will be…

KEYPOINTS: Pfizer announced that its oral antiviral cut the risk of hospitalization or death by 89% in an interim analysis of the…

SUMMARY: Sputnik-V was the world’s first registered COVID-19 vaccine, emerged in August 2020, but has not been approved by international health authorities. Russians also…

Summary- BioNTech in bid to build manufacturing expertise in Africa Project seeks to avoid repeat of COVID-19 vaccine inequality Backed by EU…

Keypoints The United States announced Friday an additional 9.6 million doses of Pfizer coronavirus vaccine are being shipped to Pakistan through the…

Key Points –   AION Labs, a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges,…

  Key Points –   SMC approved Combination of Opdivo (Nivolumab) plus  Cabometryx (Cabozantinib) for treatment of Advanced Renal Carcinoma  In a Phase III…